Use of the α-hemolysin secretion system of Escherichia coli for antigen delivery in the Salmonella typhi Ty21a vaccine strain

International Journal of Medical Microbiology

Volumn 294, Issue 6, 2004, Pages 363-371

  Gentschev, Ivaylo ^a   Dietrich, Guido ^b   Spreng, Simone ^b   Neuhaus, Beatrice ^b   Maier, Elke ^a   Benz, Roland ^a   Goebel, Werner ^a   Fensterle, Joachim ^a   Rapp, Ulf R ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Berna Biotech AG   (Switzerland)

Author keywords

Antigen; Escherichia coli hemolysin secretion system; Live bacterial vaccines (LBV); Salmonella typhi Ty21a; Vaccine carrier

Indexed keywords

ALPHA HEMOLYSIN; HEMOLYSIN; LIVE VACCINE; PLASMID VECTOR; TYPHOID VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; COMMERCIAL PHENOMENA; CONTROLLED STUDY; DRUG FORMULATION; DRUG STABILITY; ESCHERICHIA COLI; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN SECRETION; PROTEIN TRANSPORT; SALMONELLA TYPHI; STRESS; VACCINE PRODUCTION;

EID: 9144241092     PISSN: 14384221     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijmm.2004.07.010     Document Type: Article

References (36)

1. Calmette, A., Guerin, C., Negre, L., Bocquet, A., 1927. Sur la vaccination préventive des enfants nouveau-nés contre la tuberculose par le BCG. Ann. Inst. Pasteur 3, 201.
2. Dietrich, G., Spreng, S., Favre, D., Viret, J.F., Guzman, C.A., 2003a. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines. Curr. Opin. Mol. Ther. 5, 10-19.
3. Dietrich, G., Griot-Wenk, M., Metcalfe, I.C., Lang, A.B., Viret, J.F., 2003b. Experience with registered mucosal vaccines. Vaccine 21, 678-683.
4. Donner, P., Goebel, W., Demuth, A., Gentschev, I., Hess, J., Kaufmann, S. H. E., 1998. Use of a secretion vector for fertility control by oral vaccination. Patent WO-09850067.
5. Galen, J.E., Gomez-Duarte, O.G., Losonsky, G.A., Halpern, J.L., Lauderbaugh, C.S., Kaintuck, S., Reymann, M.K., Levine, M.M., 1997. A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens. Vaccine 15, 700-708.
6. Galen, J.E., Levine, M.M., 2001. Can a "flawless" live vector vaccine strain be engineered? Trends Microbiol 9, 372-376.
7. Gentschev, I., Sokolovic, Z., Mollenkopf, H.-J., Demuth, A., Hess, J., Kaufmann, S.H.E., Krohne, G.F., Goebel, W., 1995. Salmonella secreting active listeriolysin changes its intracellular localization. Infect. Immun. 63, 4202-4205.
8. Gentschev, I., Mollenkopf, H.-J., Sokolovic, Z., Hess, J., Kaufmann, S.H.E., Goebel, W., 1996. Development of antigen delivery systems based on the Escherichia coli hemolysin secretion pathway. Gene 179, 133-140.
9. Gentschev, I., Glaser, I., Goebel, W., McKeever, D.J., Musoke, A., Heussler, V.T., 1998. Delivery of the p67 sporozoite antigen of Theileria parva by using recombinant Salmonella dublin: secretion of the product enhances specific antibody responses in cattle. Infect. Immun. 66, 2060-2064.
10. Gentschev, I., Dietrich, G., Goebel, W., 2002. The hemolysin secretion system and its use in vaccine development. Trends Microbiol 10, 39-45.
11. Germanier, R., Purer, E., 1975. Isolation and characterization of Gal E mutant Ty 21 a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. J. Infect. Dis. 131, 553-558.
12. Griot-Wenk, M.E., Hartmann, K., Herzog, C., Ackermann, J., Maspes, B., 2001. Excellent long-term safety data established in a recent post-marketing surveillance for oral typhoid fever vaccine, VIVOTIF. Ital. J. Trop. Med. 6, 104-105.
13. Gomez-Duarte, O.G., Pasetti, M.F., Santiago, A., Sztein, M.B., Hoffman, S.L., Levine, M.M., 2001. Expression, extracellular secretion, and immunogenicity of the Plasmodium falciparum sporozoite surface protein 2 in Salmonella vaccine strains. Infect. Immun. 69, 1192-1198.
14. Hahn, H.P., Hess, C., Gabelsberger, J., Domdey, H., von Specht, B.U.A., 1998. Salmonella typhimurium strain genetically engineered to secrete effectively a bioactive human interleukin (hIL)-6 via the Escherichia coli hemolysin secretion apparatus. FEMS Immunol. Med. Microbiol. 20, 111-119.
15. Hess, J., Gentschev, I., Miko, D., Weizel, M., Ladel, C., Goebel, W., Kaufmann, S.H.E., 1996. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc. Natl. Acad. Sci. USA 93, 1458-1463.
16. Hormaeche, C., Khan, C., 1996. Recombinant bacteria as vaccine carriers of heterologous antigens. In: Kaufmann, S.E. (Ed.), Concepts in Vaccine Development. Walter de Gruyter. Berlin, New York, pp. 327-349.
17. Laemmli, UK., 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 115, 680-685.
18. Levine, M.M., Kaper, J.B., 1993. Live oral vaccines against cholera: an update. Vaccine 11, 207-212.
19. Levine, M.M., Ferreccio, C., Black, R.E., Germanier, R., 1987. Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation. Lancet 1, 1049-1052.
20. Levine, M.M., Ferreccio, C., Abrego, P., Martin, O.S., Ortiz, E., Cryz, S., 1999. Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine. Vaccine 17 (Suppl. 2), S22-S27.
21. Lindberg, A.A., 1998. Vaccination against enteric pathogens: from science to vaccine trials. Curr. Opin. Microbiol. 1, 116-124.
22. Ludwig, A., Jarchau, T., Benz, R., Goebel, W., 1988. The repeat domain of Escherichia coli haemolysin (HlyA) is responsible for its Ca-dependent binding to erythrocytes. Mol. Gen. Genet. 214, 553-561.
23. Mollenkopf, H., Dietrich, G., Kaufmann, S.H.E., 2001. Intracellular bacteria as targets and carriers for vaccination. Biol. Chem. 382, 521-532.
24. Nishimura, A., Morita, M., Nishimura, Y., Sugino, Y., 1990. A rapid and highly efficient method for preparation of competent Escherichia coli cells. Nucleic Acids Res 18, 6169.
25. Pasetti, M.F., Salerno-Goncalves, R., Sztein, M.B., 2002. Salmonella enlerica serovar Typhi live vector vaccines delivered intranasally elicit regional and systemic specific CD8+ major histocompatibility class I-restricted cytotoxic T lymphocytes. Infect. Immun. 70, 4009-4018.
26. Paterson, Y., 2003. Rational approaches to immune regulation. Immunol. Res. 27, 451-462.
27. Rapp, U. R., Goebel, W., Fensterle, J., Gentschev, I., 2002. Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors. Patent application (WO03072789, DE 102 08 653.2).
28. Roberts, M., Li, J., Bacon, A., Chatfield, S., 1998. Oral vaccination against tetanus: comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters. Infect. Immun. 66, 3080-3087.
29. Russmann, H., Shams, H., Poblete, F., Fu, Y., Galan, J.E., Donis, R.O., 1998. Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 281, 565-568.
30. Salerno-Goncalves, R., Pasetti, M., Sztein, M.B., 2002. Characterization of CD8(+) effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J. Immunol. 169, 2196-2203.
31. Schlor, S., Schmidt, A., Maier, E., Benz, R., Goebel, W., Gentschev, I., 1997. In vivo and in vitro studies on interactions between the components of the hemolysin (HIyA) secretion machinery of Escherichla coli. Mol. Gen. Genet. 256, 306-319.
32. Spreng, S., Dietrich, G., Goebel, W., Gentschev, I., 1999. The Escherichia coli haemolysin secretion apparatus: a potential universal antigen-delivery system in Gram-negative bacterial vaccine carriers. Mol. Microbiol. 31, 1589-1601.
33. Tijhaar, E.J., Zheng-Xin, Y., Karlas, J.A., Meyer, T.F., Stukart, M.J., Osterhaus, A.D., Mooi, F.R., 1994. Construction and evaluation of an expression vector allowing the stable expression of foreign antigens in a Salmonella typhimurium vaccine strain. Vaccine 12, 1004-1011.
34. Vogel, M., Hess, J., Then, I., Juarez, A., Goebel, W., 1988. Characterization of a sequence (hlyR) which enhances synthesis and secretion of hemolysin in Escherichia coli. Mol. Gen. Genet. 212, 76-84.
35. Wandersman, C., Delepelaire, P., 1990. TolC, an Escherichia coli outer membrane protein required for hemolysin secretion. Proc. Natl. Acad. Sci. USA 87, 4776-4780.
36. Xu, D., McSorley, S.J., Tetley, L., Chatfield, S., Dougan, G., Chan, W.L., Satoskar, A., David, J.R., Liew, F.Y., 1998. Protective effect on Leishmania major infection of migration inhibitory factor, TNF-alpha, and IFN-gamma administered orally via attenuated Salmonella typhimurium. J. Immunol. 160, 1285-1289.